← All trials
NCT06259578
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 29, 2024
- Primary completion
- Aug 29, 2024
- Completion date
- Dec 29, 2024
- First posted
- Feb 14, 2024
- Last posted
- Feb 14, 2024
- Enrollment
- 400
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Dr. Soetomo General HospitalLead sponsor
- Government of IndonesiaCollaborator
- Airlangga UniversityCollaborator
- Biotis Pharmaceuticals, IndonesiaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.